Restoring the Angiogenic Capacity of the Human Diabetic Adipose-derived mesenchymal stem cells Primed with Deferoxamine as a Hypoxia Mimetic Agent: Role of HIF-1α

Raziye Tajali ¹ , Akram Eidi ¹, Hosein Ahmadi Tafti ², Abdolreza Pazouki ³, Ali Mohammad Sharifi ^4,5,6 *

Cited by CrossRef: 2

1- Zeinhom A, Fadallah S, Mahmoud M. Human mesenchymal stem/stromal cell based-therapy in diabetes mellitus: experimental and clinical perspectives. Stem Cell Res Ther. 2024;15(1) [Crossref]

2- Ozkan S, Isildar B, Koyuturk M. Comparative analysis of the effects of different hypoxia mimetic agents on the secretome contents of conditioned medium obtained from mesenchymal stem/stromal cells cultured in 2 or 3-dimensional cell culture systems. Cytotechnology. 2025;77(1) [Crossref]